230 related articles for article (PubMed ID: 16431249)
1. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.
Saito T; Matsunaga A; Oikawa S
Am J Kidney Dis; 2006 Feb; 47(2):199-211. PubMed ID: 16431249
[TBL] [Abstract][Full Text] [Related]
2. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy.
Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Li LS
J Nephrol; 2008; 21(1):110-7. PubMed ID: 18264944
[TBL] [Abstract][Full Text] [Related]
4. A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy.
Toyota K; Hashimoto T; Ogino D; Matsunaga A; Ito M; Masakane I; Degawa N; Sato H; Shirai S; Umetsu K; Tamiya G; Saito T; Hayasaka K
J Hum Genet; 2013 May; 58(5):254-8. PubMed ID: 23407349
[TBL] [Abstract][Full Text] [Related]
5. Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.
Saito T; Ishigaki Y; Oikawa S; Yamamoto TT
Trends Cardiovasc Med; 2002 Feb; 12(2):67-70. PubMed ID: 11852253
[TBL] [Abstract][Full Text] [Related]
6. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
Bomback AS; Song H; D'Agati VD; Cohen SD; Neal A; Appel GB; Rovin BH
Nephrol Dial Transplant; 2010 Oct; 25(10):3442-6. PubMed ID: 20624773
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice.
Ishimura A; Watanabe M; Nakashima H; Ito K; Miyake K; Mochizuki S; Ishigaki Y; Saito T
Clin Exp Nephrol; 2009 Oct; 13(5):430-437. PubMed ID: 19459027
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features.
Saito T; Oikawa S; Sato H; Sato T; Ito S; Sasaki J
Kidney Int Suppl; 1999 Jul; 71():S37-41. PubMed ID: 10412734
[TBL] [Abstract][Full Text] [Related]
9. Macrophage impairment produced by Fc receptor gamma deficiency plays a principal role in the development of lipoprotein glomerulopathy in concert with apoE abnormalities.
Ito K; Nakashima H; Watanabe M; Ishimura A; Miyahara Y; Abe Y; Yasuno T; Ifuku M; Sasatomi Y; Saito T
Nephrol Dial Transplant; 2012 Oct; 27(10):3899-907. PubMed ID: 22863838
[TBL] [Abstract][Full Text] [Related]
10. [A 3-amino acid deletion of apolipoprotein E found in 3 Chinese lipoprotein glomerulopathy patients].
Chen YQ; Zhang H; Zhu SL; Zou WZ; Wang M; Liu ZS; Wang HY
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):774-7. PubMed ID: 12899757
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E-related glomerular disorders.
Saito T; Matsunaga A; Fukunaga M; Nagahama K; Hara S; Muso E
Kidney Int; 2020 Feb; 97(2):279-288. PubMed ID: 31874799
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein glomerulopathy: clinical features and pathological characteristics in Chinese.
Chen HP; Liu ZH; Gong RJ; Tang Z; Zeng CH; Zhu MY; Wang JP; Zhou H; Li LS
Chin Med J (Engl); 2004 Oct; 117(10):1513-7. PubMed ID: 15498375
[TBL] [Abstract][Full Text] [Related]
13. Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report.
Cautero N; Di Benedetto F; De Ruvo N; Montalti R; Guerrini GP; Ballarin R; Spaggiari M; Smerieri N; De Blasiis MG; Rompianesi G; Iemmolo RM; Marino M; Bertolotti M; Zivieri S; Gerunda GE
Transplant Proc; 2010 May; 42(4):1349-51. PubMed ID: 20534298
[TBL] [Abstract][Full Text] [Related]
14. Virus-mediated transduction of apolipoprotein E (ApoE)-sendai develops lipoprotein glomerulopathy in ApoE-deficient mice.
Ishigaki Y; Oikawa S; Suzuki T; Usui S; Magoori K; Kim DH; Suzuki H; Sasaki J; Sasano H; Okazaki M; Toyota T; Saito T; Yamamoto TT
J Biol Chem; 2000 Oct; 275(40):31269-73. PubMed ID: 10903326
[TBL] [Abstract][Full Text] [Related]
15. Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity.
Sakatsume M; Kadomura M; Sakata I; Imai N; Kondo D; Osawa Y; Shimada H; Ueno M; Miida T; Nishi S; Arakawa M; Gejyo F
Kidney Int; 2001 May; 59(5):1911-8. PubMed ID: 11318963
[TBL] [Abstract][Full Text] [Related]
16. Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.
Luo B; Huang F; Liu Q; Li X; Chen W; Zhou SF; Yu X
Am J Nephrol; 2008; 28(2):347-53. PubMed ID: 18046082
[TBL] [Abstract][Full Text] [Related]
17. [Identification of a mutation in exon 4 of apolipoprotein E gene in a family affected with lipoprotein glomerulopathy].
Han HL; Lin S; Sun LS; Zhang P; Zhai DP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):141-4. PubMed ID: 22487820
[TBL] [Abstract][Full Text] [Related]
18. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
Kidney Int; 1999 Aug; 56(2):421-7. PubMed ID: 10432380
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America.
da Silveira-Neto JN; de Oliveira Ahn GJ; de Menezes Neves PDM; Baptista VAF; de Almeida Araújo S; Wanderley DC; Watanabe A; Watanabe EH; Murai NM; Bertollo EMG; Vieira-Neto OM; Dantas M; de Antônio SR; Costa RS; Baptista MASF; Moysés-Neto M; Onuchic LF
Diagn Pathol; 2021 Jul; 16(1):65. PubMed ID: 34311745
[TBL] [Abstract][Full Text] [Related]
20. The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
Wu H; Yang Y; Hu Z
J Atheroscler Thromb; 2018 Aug; 25(8):733-740. PubMed ID: 29398675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
